$COLL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in COLLEGIUM PHARMACEUTICAL, INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in COLLEGIUM PHARMACEUTICAL, INC. Get notifications about new insider transactions in COLLEGIUM PHARMACEUTICAL, INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 24 2021 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Grant | A | 0.00 | 9,941 | 0 | 20,948 | 11 K to 20.9 K (+90.32 %) |
May 12 2021 | COLL | COLLEGIUM PHARMACE ... | Kuhlmann Shirley R. | EVP and General Cou ... | Sell | S | 22.77 | 7,000 | 159,390 | 89,990 | 97 K to 90 K (-7.22 %) |
Apr 05 2021 | COLL | COLLEGIUM PHARMACE ... | Malamut Richard | EVP and Chief Medic ... | Payment of Exercise | F | 23.38 | 3,119 | 72,922 | 93,558 | 96.7 K to 93.6 K (-3.23 %) |
Apr 05 2021 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | EVP & Chief Technic ... | Payment of Exercise | F | 23.38 | 7,900 | 184,702 | 145,080 | 153 K to 145.1 K (-5.16 %) |
Apr 05 2021 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | EVP & Chief Technic ... | Payment of Exercise | F | 23.38 | 1,757 | 41,079 | 152,980 | 154.7 K to 153 K (-1.14 %) |
Mar 18 2021 | COLL | COLLEGIUM PHARMACE ... | Kuhlmann Shirley R. | EVP and General Cou ... | Payment of Exercise | F | 24.69 | 734 | 18,122 | 96,990 | 97.7 K to 97 K (-0.75 %) |
Mar 17 2021 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Director | Sell | S | 25.88 | 3,031 | 78,442 | 4,047 | 7.1 K to 4 K (-42.82 %) |
Mar 17 2021 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Director | Sell | S | 25.26 | 47,044 | 1,188,331 | 7,078 | 54.1 K to 7.1 K (-86.92 %) |
Mar 03 2021 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | President and CEO | Option Exercise | M | 8.22 | 48,616 | 399,624 | 16,205 | |
Mar 03 2021 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | President and CEO | Sell | S | 23.30 | 9,809 | 228,550 | 278,307 | 288.1 K to 278.3 K (-3.40 %) |
Mar 03 2021 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | President and CEO | Sell | S | 22.56 | 54,959 | 1,239,875 | 288,116 | 343.1 K to 288.1 K (-16.02 %) |
Mar 03 2021 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | President and CEO | Buy | M | 8.22 | 48,616 | 399,624 | 343,075 | 294.5 K to 343.1 K (+16.51 %) |
Mar 03 2021 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technical Off ... | Option Exercise | M | 3.31 | 1,449 | 4,796 | 0 | |
Mar 03 2021 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technical Off ... | Option Exercise | M | 0.90 | 1,811 | 1,630 | 0 | |
Mar 03 2021 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technical Off ... | Option Exercise | M | 0.90 | 64 | 58 | 0 | |
Mar 03 2021 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technical Off ... | Option Exercise | M | 0.48 | 5,753 | 2,761 | 0 | |
Mar 03 2021 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technical Off ... | Option Exercise | M | 0.90 | 1,747 | 1,572 | 64 | |
Mar 03 2021 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technical Off ... | Sell | S | 23.36 | 6,011 | 140,417 | 148,753 | 154.8 K to 148.8 K (-3.88 %) |
Mar 03 2021 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technical Off ... | Sell | S | 27.00 | 1,400 | 37,800 | 154,764 | 156.2 K to 154.8 K (-0.90 %) |
Mar 03 2021 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technical Off ... | Sell | S | 23.00 | 1,449 | 33,327 | 156,164 | 157.6 K to 156.2 K (-0.92 %) |
Mar 03 2021 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technical Off ... | Buy | M | 3.31 | 1,449 | 4,796 | 157,613 | 156.2 K to 157.6 K (+0.93 %) |
Mar 03 2021 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technical Off ... | Sell | S | 23.00 | 1,811 | 41,653 | 156,164 | 158 K to 156.2 K (-1.15 %) |
Mar 03 2021 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technical Off ... | Buy | M | 0.90 | 1,811 | 1,630 | 157,975 | 156.2 K to 158 K (+1.16 %) |
Mar 03 2021 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technical Off ... | Sell | S | 23.00 | 64 | 1,472 | 156,164 | 156.2 K to 156.2 K (-0.04 %) |
Mar 03 2021 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technical Off ... | Buy | M | 0.90 | 64 | 58 | 156,228 | 156.2 K to 156.2 K (+0.04 %) |
Mar 03 2021 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technical Off ... | Sell | S | 21.00 | 5,753 | 120,813 | 156,164 | 161.9 K to 156.2 K (-3.55 %) |
Mar 03 2021 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technical Off ... | Buy | M | 0.48 | 5,753 | 2,761 | 161,917 | 156.2 K to 161.9 K (+3.68 %) |
Mar 03 2021 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technical Off ... | Sell | S | 21.00 | 1,747 | 36,687 | 156,164 | 157.9 K to 156.2 K (-1.11 %) |
Mar 03 2021 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technical Off ... | Buy | M | 0.90 | 1,747 | 1,572 | 157,911 | 156.2 K to 157.9 K (+1.12 %) |
Feb 12 2021 | COLL | COLLEGIUM PHARMACE ... | Malamut Richard | EVP and Chief Medic ... | Payment of Exercise | F | 25.95 | 1,542 | 40,015 | 96,677 | 98.2 K to 96.7 K (-1.57 %) |
Feb 12 2021 | COLL | COLLEGIUM PHARMACE ... | Malamut Richard | EVP and Chief Medic ... | Payment of Exercise | F | 25.95 | 758 | 19,670 | 98,219 | 99 K to 98.2 K (-0.77 %) |
Jan 21 2021 | COLL | COLLEGIUM PHARMACE ... | Malamut Richard | EVP and Chief Medic ... | Option Exercise | A | 24.06 | 105,600 | 2,540,736 | 105,600 | |
Jan 21 2021 | COLL | COLLEGIUM PHARMACE ... | Malamut Richard | EVP and Chief Medic ... | Grant | A | 0.00 | 2,187 | 0 | 98,977 | 96.8 K to 99 K (+2.26 %) |
Jan 21 2021 | COLL | COLLEGIUM PHARMACE ... | Malamut Richard | EVP and Chief Medic ... | Grant | A | 0.00 | 36,960 | 0 | 96,790 | 59.8 K to 96.8 K (+61.78 %) |
Jan 21 2021 | COLL | COLLEGIUM PHARMACE ... | Dreyer Scott | EVP & Chief Commerc ... | Option Exercise | A | 24.06 | 130,800 | 3,147,048 | 130,800 | |
Jan 21 2021 | COLL | COLLEGIUM PHARMACE ... | Dreyer Scott | EVP & Chief Commerc ... | Grant | A | 0.00 | 6,165 | 0 | 96,340 | 90.2 K to 96.3 K (+6.84 %) |
Jan 21 2021 | COLL | COLLEGIUM PHARMACE ... | Dreyer Scott | EVP & Chief Commerc ... | Grant | A | 0.00 | 45,780 | 0 | 90,175 | 44.4 K to 90.2 K (+103.12 %) |
Jan 21 2021 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Option Exercise | A | 24.06 | 120,000 | 2,887,200 | 120,000 | |
Jan 21 2021 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Grant | A | 0.00 | 8,161 | 0 | 223,919 | 215.8 K to 223.9 K (+3.78 %) |
Jan 21 2021 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Grant | A | 0.00 | 42,000 | 0 | 215,758 | 173.8 K to 215.8 K (+24.17 %) |
Jan 21 2021 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | President and CEO | Option Exercise | A | 24.06 | 420,000 | 10,105,200 | 420,000 | |
Jan 21 2021 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | President and CEO | Grant | A | 0.00 | 28,989 | 0 | 318,245 | 289.3 K to 318.2 K (+10.02 %) |
Jan 21 2021 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | President and CEO | Grant | A | 0.00 | 105,000 | 0 | 289,256 | 184.3 K to 289.3 K (+56.99 %) |
Jan 20 2021 | COLL | COLLEGIUM PHARMACE ... | Dreyer Scott | EVP & Chief Commerc ... | Sell | S | 22.89 | 1,322 | 30,261 | 44,395 | 45.7 K to 44.4 K (-2.89 %) |
Jan 13 2021 | COLL | COLLEGIUM PHARMACE ... | Dreyer Scott | EVP & Chief Commerc ... | Payment of Exercise | F | 21.18 | 701 | 14,847 | 45,717 | 46.4 K to 45.7 K (-1.51 %) |
Jan 11 2021 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Option Exercise | M | 5.73 | 16,042 | 91,921 | 0 | |
Jan 11 2021 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Option Exercise | M | 5.73 | 3,336 | 19,115 | 16,042 | |
Jan 11 2021 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Sell | S | 22.00 | 16,042 | 352,924 | 111,419 | 127.5 K to 111.4 K (-12.59 %) |
Jan 11 2021 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Buy | M | 5.73 | 16,042 | 91,921 | 127,461 | 111.4 K to 127.5 K (+14.40 %) |
Jan 11 2021 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Sell | S | 23.00 | 3,336 | 76,728 | 111,419 | 114.8 K to 111.4 K (-2.91 %) |
Jan 11 2021 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Buy | M | 5.73 | 3,336 | 19,115 | 114,755 | 111.4 K to 114.8 K (+2.99 %) |
Jan 06 2021 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | President and CEO | Payment of Exercise | F | 20.03 | 1,090 | 21,833 | 184,256 | 185.3 K to 184.3 K (-0.59 %) |
Dec 07 2020 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Sell | S | 19.24 | 5,967 | 114,805 | 111,419 | 117.4 K to 111.4 K (-5.08 %) |
Dec 02 2020 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | President and CEO | Payment of Exercise | F | 18.49 | 4,672 | 86,385 | 185,346 | 190 K to 185.3 K (-2.46 %) |
Nov 20 2020 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Option Exercise | M | 5.73 | 16,000 | 91,680 | 19,378 | |
Nov 20 2020 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Buy | M | 5.73 | 16,000 | 91,680 | 117,386 | 101.4 K to 117.4 K (+15.78 %) |
Oct 16 2020 | COLL | COLLEGIUM PHARMACE ... | Kuhlmann Shirley R. | EVP and General Cou ... | Sell | S | 20.82 | 7,060 | 146,989 | 57,531 | 64.6 K to 57.5 K (-10.93 %) |
Sep 28 2020 | COLL | COLLEGIUM PHARMACE ... | Balice-Gordon Rita J. | Director | Option Exercise | A | 17.77 | 10,055 | 178,677 | 10,055 | |
Sep 28 2020 | COLL | COLLEGIUM PHARMACE ... | Balice-Gordon Rita J. | Director | Grant | A | 0.00 | 5,027 | 0 | 5,027 | 0 to 5 K |
Sep 18 2020 | COLL | COLLEGIUM PHARMACE ... | Kuhlmann Shirley R. | EVP and General Cou ... | Payment of Exercise | F | 19.33 | 734 | 14,188 | 64,591 | 65.3 K to 64.6 K (-1.12 %) |
Aug 12 2020 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Payment of Exercise | F | 18.89 | 1,515 | 28,618 | 173,758 | 175.3 K to 173.8 K (-0.86 %) |
Aug 12 2020 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | President and CEO | Payment of Exercise | F | 18.89 | 1,386 | 26,182 | 190,018 | 191.4 K to 190 K (-0.72 %) |
Jul 14 2020 | COLL | COLLEGIUM PHARMACE ... | Dreyer Scott | EVP & Chief Commerc ... | Sell | S | 17.01 | 1,429 | 24,307 | 46,418 | 47.8 K to 46.4 K (-2.99 %) |
Jul 14 2020 | COLL | COLLEGIUM PHARMACE ... | Dreyer Scott | EVP & Chief Commerc ... | Payment of Exercise | F | 16.73 | 594 | 9,938 | 47,847 | 48.4 K to 47.8 K (-1.23 %) |
Jun 02 2020 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | President and CEO | Option Exercise | M | 8.22 | 64,820 | 532,820 | 64,821 | |
Jun 02 2020 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | President and CEO | Sell | S | 21.30 | 100 | 2,130 | 192,798 | 192.9 K to 192.8 K (-0.05 %) |
Jun 02 2020 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | President and CEO | Sell | S | 20.47 | 5,761 | 117,928 | 192,898 | 198.7 K to 192.9 K (-2.90 %) |
Jun 02 2020 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | President and CEO | Sell | S | 22.08 | 100 | 2,208 | 198,659 | 198.8 K to 198.7 K (-0.05 %) |
Jun 02 2020 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | President and CEO | Sell | S | 21.53 | 70,576 | 1,519,501 | 198,759 | 269.3 K to 198.8 K (-26.20 %) |
Jun 02 2020 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | President and CEO | Buy | M | 8.22 | 64,820 | 532,820 | 269,335 | 204.5 K to 269.3 K (+31.69 %) |
Jun 02 2020 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | President and CEO | Payment of Exercise | F | 21.24 | 4,672 | 99,233 | 204,515 | 209.2 K to 204.5 K (-2.23 %) |
May 22 2020 | COLL | COLLEGIUM PHARMACE ... | SANTINI GINO | Director | Option Exercise | A | 22.05 | 8,095 | 178,495 | 8,095 | |
May 22 2020 | COLL | COLLEGIUM PHARMACE ... | SANTINI GINO | Director | Grant | A | 0.00 | 4,047 | 0 | 34,195 | 30.1 K to 34.2 K (+13.42 %) |
May 22 2020 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Option Exercise | A | 22.05 | 8,095 | 178,495 | 8,095 | |
May 22 2020 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Grant | A | 0.00 | 4,047 | 0 | 11,007 | 7 K to 11 K (+58.15 %) |
May 22 2020 | COLL | COLLEGIUM PHARMACE ... | Fallon John A. | Director | Option Exercise | A | 22.05 | 8,095 | 178,495 | 8,095 | |
May 22 2020 | COLL | COLLEGIUM PHARMACE ... | Fallon John A. | Director | Grant | A | 0.00 | 4,047 | 0 | 13,382 | 9.3 K to 13.4 K (+43.35 %) |
May 22 2020 | COLL | COLLEGIUM PHARMACE ... | Schroeder Theodore R | Director | Option Exercise | A | 22.05 | 8,095 | 178,495 | 8,095 | |
May 22 2020 | COLL | COLLEGIUM PHARMACE ... | Schroeder Theodore R | Director | Grant | A | 0.00 | 4,047 | 0 | 11,007 | 7 K to 11 K (+58.15 %) |
May 22 2020 | COLL | COLLEGIUM PHARMACE ... | Melincoff Gwen A | Director | Option Exercise | A | 22.05 | 8,095 | 178,495 | 8,095 | |
May 22 2020 | COLL | COLLEGIUM PHARMACE ... | Melincoff Gwen A | Director | Grant | A | 0.00 | 4,047 | 0 | 11,007 | 7 K to 11 K (+58.15 %) |
May 22 2020 | COLL | COLLEGIUM PHARMACE ... | BOHLIN GAREN G | Director | Option Exercise | A | 22.05 | 8,095 | 178,495 | 8,095 | |
May 22 2020 | COLL | COLLEGIUM PHARMACE ... | BOHLIN GAREN G | Director | Grant | A | 0.00 | 4,047 | 0 | 11,007 | 7 K to 11 K (+58.15 %) |
May 20 2020 | COLL | COLLEGIUM PHARMACE ... | Dreyer Scott | EVP & Chief Commerc ... | Option Exercise | M | 15.90 | 8,000 | 127,200 | 17,600 | |
May 20 2020 | COLL | COLLEGIUM PHARMACE ... | Dreyer Scott | EVP & Chief Commerc ... | Sell | S | 24.00 | 8,000 | 192,000 | 48,441 | 56.4 K to 48.4 K (-14.17 %) |
May 20 2020 | COLL | COLLEGIUM PHARMACE ... | Dreyer Scott | EVP & Chief Commerc ... | Buy | M | 15.90 | 8,000 | 127,200 | 56,441 | 48.4 K to 56.4 K (+16.51 %) |
May 15 2020 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Director | Sell | S | 22.64 | 5,905 | 133,689 | 81,796 | 87.7 K to 81.8 K (-6.73 %) |
May 15 2020 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Director | Sell | S | 21.21 | 11,969 | 253,862 | 87,701 | 99.7 K to 87.7 K (-12.01 %) |
May 15 2020 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Director | Sell | S | 20.92 | 1,380 | 28,870 | 99,670 | 101.1 K to 99.7 K (-1.37 %) |
Mar 18 2020 | COLL | COLLEGIUM PHARMACE ... | Kuhlmann Shirley R. | EVP and General Cou ... | Payment of Exercise | F | 15.41 | 734 | 11,311 | 65,325 | 66.1 K to 65.3 K (-1.11 %) |
Feb 12 2020 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Payment of Exercise | F | 21.62 | 4,025 | 87,021 | 175,273 | 179.3 K to 175.3 K (-2.24 %) |
Feb 12 2020 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Payment of Exercise | F | 21.62 | 3,568 | 77,140 | 110,890 | 114.5 K to 110.9 K (-3.12 %) |
Feb 12 2020 | COLL | COLLEGIUM PHARMACE ... | Dreyer Scott | EVP & Chief Commerc ... | Payment of Exercise | F | 21.62 | 1,966 | 42,505 | 52,875 | 54.8 K to 52.9 K (-3.58 %) |
Feb 12 2020 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Director | Payment of Exercise | F | 21.62 | 4,962 | 107,278 | 101,050 | 106 K to 101.1 K (-4.68 %) |
Feb 07 2020 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Option Exercise | A | 21.34 | 25,000 | 533,500 | 25,000 | |
Feb 07 2020 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Grant | A | 0.00 | 18,616 | 0 | 114,458 | 95.8 K to 114.5 K (+19.42 %) |
Feb 07 2020 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Grant | A | 0.00 | 22,500 | 0 | 95,842 | 73.3 K to 95.8 K (+30.68 %) |
Feb 07 2020 | COLL | COLLEGIUM PHARMACE ... | Malamut Richard | EVP and Chief Medic ... | Option Exercise | A | 21.34 | 22,500 | 480,150 | 22,500 | |
Feb 07 2020 | COLL | COLLEGIUM PHARMACE ... | Malamut Richard | EVP and Chief Medic ... | Grant | A | 0.00 | 20,250 | 0 | 62,750 | 42.5 K to 62.8 K (+47.65 %) |
Feb 07 2020 | COLL | COLLEGIUM PHARMACE ... | Kuhlmann Shirley R. | EVP and General Cou ... | Option Exercise | A | 21.34 | 27,500 | 586,850 | 27,500 | |
Feb 07 2020 | COLL | COLLEGIUM PHARMACE ... | Kuhlmann Shirley R. | EVP and General Cou ... | Grant | A | 0.00 | 24,750 | 0 | 68,144 | 43.4 K to 68.1 K (+57.04 %) |
Feb 07 2020 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | President and CEO | Option Exercise | A | 21.34 | 90,000 | 1,920,600 | 90,000 | |
Feb 07 2020 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | President and CEO | Grant | A | 0.00 | 45,000 | 0 | 216,686 | 171.7 K to 216.7 K (+26.21 %) |
Jan 22 2020 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Director | Option Exercise | M | 5.73 | 275,463 | 1,578,403 | 0 | |
Jan 22 2020 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Director | Payment of Exercise | F | 21.56 | 787 | 16,968 | 106,012 | 106.8 K to 106 K (-0.74 %) |
Jan 22 2020 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Director | Sell | S | 22.69 | 32,700 | 741,963 | 106,799 | 139.5 K to 106.8 K (-23.44 %) |
Jan 22 2020 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Director | Sell | S | 21.84 | 262,587 | 5,734,900 | 139,499 | 402.1 K to 139.5 K (-65.31 %) |
Jan 22 2020 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Director | Buy | M | 5.73 | 275,463 | 1,578,403 | 402,086 | 126.6 K to 402.1 K (+217.55 %) |
Jan 22 2020 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Payment of Exercise | F | 21.56 | 214 | 4,614 | 73,342 | 73.6 K to 73.3 K (-0.29 %) |
Jan 22 2020 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Payment of Exercise | F | 21.56 | 214 | 4,614 | 151,173 | 151.4 K to 151.2 K (-0.14 %) |
Jan 16 2020 | COLL | COLLEGIUM PHARMACE ... | Dreyer Scott | EVP & Chief Commerc ... | Sell | S | 23.87 | 1,321 | 31,532 | 35,716 | 37 K to 35.7 K (-3.57 %) |
Jan 14 2020 | COLL | COLLEGIUM PHARMACE ... | Dreyer Scott | EVP & Chief Commerc ... | Payment of Exercise | F | 23.30 | 702 | 16,357 | 37,037 | 37.7 K to 37 K (-1.86 %) |
Dec 04 2019 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Buy | J | 0.00 | 8,625 | 0 | 8,625 | 0 to 8.6 K |
Dec 04 2019 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Sell | J | 0.00 | 574,916 | 0 | 0 | 574.9 K to 0 (-100.00 %) |
Dec 02 2019 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | President and CEO | Payment of Exercise | F | 21.73 | 4,678 | 101,653 | 172,777 | 177.5 K to 172.8 K (-2.64 %) |
Nov 13 2019 | COLL | COLLEGIUM PHARMACE ... | Hirsch David | Director | Sell | S | 19.33 | 25,000 | 483,250 | 17,117 | 42.1 K to 17.1 K (-59.36 %) |
Nov 13 2019 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Option Exercise | M | 5.73 | 25,000 | 143,250 | 35,378 | |
Nov 13 2019 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Sell | S | 19.44 | 25,000 | 486,000 | 73,556 | 98.6 K to 73.6 K (-25.37 %) |
Nov 13 2019 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Buy | M | 5.73 | 25,000 | 143,250 | 98,556 | 73.6 K to 98.6 K (+33.99 %) |
Nov 08 2019 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | President and CEO | Option Exercise | M | 8.22 | 64,821 | 532,829 | 129,641 | |
Nov 08 2019 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | President and CEO | Sell | S | 19.16 | 31,226 | 598,290 | 177,455 | 208.7 K to 177.5 K (-14.96 %) |
Nov 08 2019 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | President and CEO | Sell | S | 18.41 | 33,595 | 618,484 | 208,681 | 242.3 K to 208.7 K (-13.87 %) |
Nov 08 2019 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | President and CEO | Buy | M | 8.22 | 64,821 | 532,829 | 242,276 | 177.5 K to 242.3 K (+36.53 %) |
Sep 18 2019 | COLL | COLLEGIUM PHARMACE ... | Kuhlmann Shirley R. | EVP and General Cou ... | Payment of Exercise | F | 12.44 | 736 | 9,156 | 43,394 | 44.1 K to 43.4 K (-1.67 %) |
Sep 03 2019 | COLL | COLLEGIUM PHARMACE ... | Hirsch David | Director | Option Exercise | M | 9.33 | 19,853 | 185,228 | 0 | |
Sep 03 2019 | COLL | COLLEGIUM PHARMACE ... | Hirsch David | Director | Sell | S | 11.65 | 22,106 | 257,535 | 42,117 | 64.2 K to 42.1 K (-34.42 %) |
Sep 03 2019 | COLL | COLLEGIUM PHARMACE ... | Hirsch David | Director | Buy | M | 9.33 | 19,853 | 185,228 | 64,223 | 44.4 K to 64.2 K (+44.74 %) |
Aug 13 2019 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Payment of Exercise | F | 11.24 | 1,517 | 17,051 | 73,556 | 75.1 K to 73.6 K (-2.02 %) |
Aug 13 2019 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | President and CEO | Payment of Exercise | F | 11.24 | 919 | 10,330 | 177,455 | 178.4 K to 177.5 K (-0.52 %) |
Aug 13 2019 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Director | Payment of Exercise | F | 11.24 | 4,779 | 53,716 | 126,623 | 131.4 K to 126.6 K (-3.64 %) |
Aug 13 2019 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Payment of Exercise | F | 11.24 | 1,517 | 17,051 | 151,387 | 152.9 K to 151.4 K (-0.99 %) |
Aug 13 2019 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Grant | A | 9.04 | 797 | 7,205 | 152,904 | 152.1 K to 152.9 K (+0.52 %) |
Aug 13 2019 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Payment of Exercise | F | 11.24 | 1,517 | 17,051 | 73,556 | 75.1 K to 73.6 K (-2.02 %) |
Aug 13 2019 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | President and CEO | Payment of Exercise | F | 11.24 | 919 | 10,330 | 177,455 | 178.4 K to 177.5 K (-0.52 %) |
Aug 13 2019 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Director | Payment of Exercise | F | 11.24 | 4,779 | 53,716 | 126,623 | 131.4 K to 126.6 K (-3.64 %) |
Aug 13 2019 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Payment of Exercise | F | 11.24 | 1,517 | 17,051 | 151,387 | 152.9 K to 151.4 K (-0.99 %) |
Aug 13 2019 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Grant | A | 9.04 | 797 | 7,205 | 152,904 | 152.1 K to 152.9 K (+0.52 %) |
Jul 23 2019 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technology Of ... | Payment of Exercise | F | 10.35 | 181 | 1,873 | 75,073 | 75.3 K to 75.1 K (-0.24 %) |
Jul 23 2019 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Director | Payment of Exercise | F | 10.35 | 667 | 6,903 | 131,402 | 132.1 K to 131.4 K (-0.51 %) |
Jul 23 2019 | COLL | COLLEGIUM PHARMACE ... | Brannelly Paul | Executive Vice Pres ... | Payment of Exercise | F | 10.35 | 181 | 1,873 | 152,107 | 152.3 K to 152.1 K (-0.12 %) |
Jul 17 2019 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Director | Sell | S | 11.26 | 25,000 | 281,500 | 132,069 | 157.1 K to 132.1 K (-15.92 %) |
Jul 12 2019 | COLL | COLLEGIUM PHARMACE ... | Dreyer Scott | EVP & Chief Commerc ... | Sell | S | 12.31 | 2,857 | 35,170 | 37,739 | 40.6 K to 37.7 K (-7.04 %) |
Jul 12 2019 | COLL | COLLEGIUM PHARMACE ... | Dreyer Scott | EVP & Chief Commerc ... | Payment of Exercise | F | 12.44 | 1,190 | 14,804 | 40,596 | 41.8 K to 40.6 K (-2.85 %) |
Jul 02 2019 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | President and CEO | Payment of Exercise | F | 13.21 | 1,848 | 24,412 | 178,374 | 180.2 K to 178.4 K (-1.03 %) |
Jun 19 2019 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Director | Sell | S | 12.05 | 2,021 | 24,353 | 157,069 | 159.1 K to 157.1 K (-1.27 %) |
Jun 19 2019 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Director | Sell | S | 11.31 | 22,979 | 259,892 | 159,090 | 182.1 K to 159.1 K (-12.62 %) |
Jun 04 2019 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | President and CEO | Sell | S | 11.59 | 7,436 | 86,183 | 180,222 | 187.7 K to 180.2 K (-3.96 %) |
Jun 04 2019 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | President and CEO | Payment of Exercise | F | 11.51 | 3,097 | 35,646 | 187,658 | 190.8 K to 187.7 K (-1.62 %) |
Jun 04 2019 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | President and CEO | Sell | S | 11.52 | 5,851 | 67,404 | 190,755 | 196.6 K to 190.8 K (-2.98 %) |
Apr 30 2019 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Director | Option Exercise | A | 14.57 | 9,414 | 137,162 | 9,414 |